These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8151703)

  • 21. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The solution structures of mutant calbindin D9k's, as determined by NMR, show that the calcium-binding site can adopt different folds.
    Johansson C; Ullner M; Drakenberg T
    Biochemistry; 1993 Aug; 32(33):8429-38. PubMed ID: 8357794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution structure of human prolactin.
    Teilum K; Hoch JC; Goffin V; Kinet S; Martial JA; Kragelund BB
    J Mol Biol; 2005 Aug; 351(4):810-23. PubMed ID: 16045928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling of the GM-CSF and IL-3 receptor complexes.
    Lyne PD; Bamborough P; Duncan D; Richards WG
    Protein Sci; 1995 Oct; 4(10):2223-33. PubMed ID: 8535258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant opioid receptors. Structure-function relationship.
    Filipovska J; Gomes I; Xu W; Chen C; Liu-Chen LY; Devi LA
    Methods Mol Med; 2003; 84():185-203. PubMed ID: 12703324
    [No Abstract]   [Full Text] [Related]  

  • 27. Follitropin conformational stability mediated by loop 2 beta effects follitropin-receptor interaction.
    Roth KE; Dias JA
    Biochemistry; 1996 Jun; 35(24):7928-35. PubMed ID: 8672495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteine scanning mutagenesis at 40 of 76 positions in villin headpiece maps the F-actin binding site and structural features of the domain.
    Doering DS; Matsudaira P
    Biochemistry; 1996 Oct; 35(39):12677-85. PubMed ID: 8841111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
    Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
    Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling.
    Fernandez LM; Puett D
    Biochemistry; 1996 Apr; 35(13):3986-93. PubMed ID: 8672431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental and theoretical studies of the three-dimensional structure of human interleukin-4.
    Curtis BM; Presnell SR; Srinivasan S; Sassenfeld H; Klinke R; Jeffery E; Cosman D; March CJ; Cohen FE
    Proteins; 1991; 11(2):111-9. PubMed ID: 1946344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR and X-ray analysis of the three-dimensional structure of interleukin-8.
    Clore GM; Gronenborn AM
    Cytokines; 1992; 4():18-40. PubMed ID: 1472915
    [No Abstract]   [Full Text] [Related]  

  • 33. The interleukin-2 and interleukin-4 receptors studied by molecular modelling.
    Bamborough P; Hedgecock CJ; Richards WG
    Structure; 1994 Sep; 2(9):839-51. PubMed ID: 7529123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor binding properties of four-helix-bundle growth factors deduced from electrostatic analysis.
    Demchuk E; Mueller T; Oschkinat H; Sebald W; Wade RC
    Protein Sci; 1994 Jun; 3(6):920-35. PubMed ID: 7520794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4.
    Reusch P; Arnold S; Heusser C; Wagner K; Weston B; Sebald W
    Eur J Biochem; 1994 Jun; 222(2):491-9. PubMed ID: 7517357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A computer model of the interleukin-4/receptor complex.
    Bamborough P; Grant GH; Hedgecock CJ; West SP; Richards WG
    Proteins; 1993 Sep; 17(1):11-9. PubMed ID: 8234241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stoichiometry of the complex of human interleukin-4 with its receptor.
    Hoffman RC; Schalk-Hihi C; Castner BJ; Gibson MG; Rasmussen BD; Zdanov A; Gustchina A; March CJ; Wlodawer A
    FEBS Lett; 1994 Jun; 347(1):17-21. PubMed ID: 8013654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural model of human IL-13 defines the spatial interactions with the IL-13Ralpha/IL-4Ralpha receptor.
    Zuegg J; Webb DC; Foster PS; Casarotto MG
    Immunol Cell Biol; 2001 Aug; 79(4):332-9. PubMed ID: 11488979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interleukin-4 receptor: structure, function, and signal transduction.
    Beckmann MP; Cosman D; Fanslow W; Maliszewski CR; Lyman SD
    Chem Immunol; 1992; 51():107-34. PubMed ID: 1567539
    [No Abstract]   [Full Text] [Related]  

  • 40. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein.
    Shen BJ; Hage T; Sebald W
    Eur J Biochem; 1996 Aug; 240(1):252-61. PubMed ID: 8797861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.